Cargando…

Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload

Suitable content of iron is essential for human body, but iron overload is associated with many kinds of diseases including chronic liver damage. Recently, researchers find that iron overload promotes hepatocyte autophagy and apoptosis. However, the mechanism of iron overload in liver damage remains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Dongyu, Zhou, Ping, Liu, Lin, Jiang, Wenjing, Xie, Haina, Zhang, Liang, Xie, Donghao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683835/ https://www.ncbi.nlm.nih.gov/pubmed/31428632 http://dx.doi.org/10.1155/2019/3103946

Ejemplares similares

Qizhufang (ZSF) Ameliorates Hepatic Iron Overload via Signal Transducer and Activator of Transcription 3 (STAT3) Pathway
por: Xie, Dongyu, et al.
Publicado: (2019)

ARHGAP10 Inhibits the Proliferation and Metastasis of CRC Cells via Blocking the Activity of RhoA/AKT Signaling Pathway
por: Liu, Lin, et al.
Publicado: (2019)

Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy
por: Ding, Yuzhi, et al.
Publicado: (2014)

Astragaloside IV ameliorates renal injury in db/db mice
por: Sun, Huili, et al.
Publicado: (2016)

ROS/NF-κB Signaling Pathway-Mediated Transcriptional Activation of TRIM37 Promotes HBV-Associated Hepatic Fibrosis
por: Xie, Haina, et al.
Publicado: (2020)

Astragaloside IV protects RGC-5 cells against oxidative stress
por: Hao, Ming, et al.
Publicado: (2018)

Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a
por: Wu, Yang, et al.
Publicado: (2020)

Protective effect of Astragaloside IV against sepsis-induced acute lung injury in rats
por: Huang, Ruiqin, et al.
Publicado: (2016)

Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury
por: Tang, Jia-Long, et al.
Publicado: (2022)

Review on the protective mechanism of astragaloside IV against cardiovascular diseases
por: Yang, Chunkun, et al.
Publicado: (2023)

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
por: Tan, Junlan, et al.
Publicado: (2023)

Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
por: Xia, Mei-Ling, et al.
Publicado: (2020)

Evaluation of astragaloside IV in hepatic fibrosis: A meta-analysis
por: Han, Zhongying, et al.
Publicado: (2021)

Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury
por: Kang, Xianhui, et al.
Publicado: (2021)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Astragaloside IV protects against iron loading‐induced abnormal differentiation of bone marrow mesenchymal stem cells (BMSCs)
por: Jin, Hui, et al.
Publicado: (2021)

Pharmacological Effects of Astragaloside IV: A Review
por: Liang, Yutong, et al.
Publicado: (2023)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination
por: Zhang, Jingxian, et al.
Publicado: (2022)

Astragaloside IV Alleviates Infarction Induced Cardiomyocyte Injury by Improving Mitochondrial Morphology and Function
por: Zhang, Wen, et al.
Publicado: (2022)

Astragaloside IV protects rat retinal capillary endothelial cells against high glucose-induced oxidative injury
por: Qiao, Yuan, et al.
Publicado: (2017)

Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats
por: Fan, Yuyan, et al.
Publicado: (2019)

Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation
por: Zhang, Yudi, et al.
Publicado: (2020)

Astragaloside IV Protects Ethanol-Induced Gastric Mucosal Injury by Preventing Mitochondrial Oxidative Stress and the Activation of Mitochondrial Pathway Apoptosis in Rats
por: Qin, Shumin, et al.
Publicado: (2019)

Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy
por: Luo, Li-Fei, et al.
Publicado: (2021)

Astragaloside IV protects against apoptosis in human degenerative chondrocytes through autophagy activation
por: Liu, Jianhong, et al.
Publicado: (2017)

Astragalosidic Acid: A New Water-Soluble Derivative of Astragaloside IV Prepared Using Remarkably Simple TEMPO-Mediated Oxidation
por: Qing, Lin-Sen, et al.
Publicado: (2017)

The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure
por: Sui, Yan-Bo, et al.
Publicado: (2020)

Astragaloside IV Enhances Cisplatin Chemosensitivity in Human Colorectal Cancer via Regulating NOTCH3
por: Xie, Tao, et al.
Publicado: (2016)

Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
por: Yuan, Fanyi, et al.
Publicado: (2023)

Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress
por: Wang, Zeng Si, et al.
Publicado: (2015)

Therapeutic Effects of Astragaloside IV on Myocardial Injuries: Multi-Target Identification and Network Analysis
por: Zhao, Jing, et al.
Publicado: (2012)

HIF-1α Signaling Activation by Post-Ischemia Treatment with Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury
por: Si, Jingwen, et al.
Publicado: (2014)

Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts
por: Wang, Zhen-Fei, et al.
Publicado: (2017)

Cellular Electrophysiology of Iron-Overloaded Cardiomyocytes
por: Siri-Angkul, Natthaphat, et al.
Publicado: (2018)

Protective Effects of Astragaloside IV on Uric Acid-Induced Pancreatic β-Cell Injury through PI3K/AKT Pathway Activation
por: Jiang, Zhenhuan, et al.
Publicado: (2022)

Preliminary study on the anti-apoptotic mechanism of Astragaloside IV on radiation-induced brain cells
por: Liu, Xin, et al.
Publicado: (2020)

Astragaloside IV Alleviates Brain Injury Induced by Hypoxia via the Calpain-1 Signaling Pathway
por: Meng, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4chtlgihl5ufjm1eik76ekbl0s